US Patent 7683171 1

Patent 7683171 was granted and assigned to Bristol-Myers Squibb on March, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7683171

Date of Patent

March 23, 2010

Patent Application Number

11346986

Date Filed

February 3, 2006

Patent Citations Received

‌

US Patent 11851442 Tricyclic fused thiophene derivatives as JAK inhibitors

‌

US Patent 11744832 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

‌

US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms

Patent Primary Examiner

‌

Rita J Desai

Patent abstract

The present invention provides for thiazolopyridine-based tricyclic compounds having the formula (I),

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7683171 1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API